Skip to main content
Optomed Oyj logo

Optomed Oyj — Investor Relations & Filings

Ticker · OPTOMED ISIN · FI4000410881 LEI · 7437009IVYWGEE4S7B77 HE Manufacturing
Open in API
Filings indexed 613 across all filing types
Latest filing 2024-04-29 Legal Proceedings Report
Country FI Finland
Listing HE OPTOMED

About Optomed Oyj

https://www.optomed.com/

Optomed is a medical technology company that develops, commercializes, and manufactures handheld fundus cameras and related artificial intelligence (AI) solutions. The company specializes in portable retinal imaging devices designed for the early detection of blinding eye diseases, such as diabetic retinopathy, and other health conditions. Its technology combines portable hardware with AI-powered software to provide real-time analysis and results, enabling comprehensive eye screenings in various healthcare settings, from primary care clinics to emergency rooms. The solutions are designed to integrate into existing clinical workflows, improving access to eye care and transforming routine screenings into comprehensive health assessments.

Recent filings

Filing Released Lang Actions
Optomedilla ei ole päivitettävää Optomed Aurora AEYE:n FDA-lupaprosessiin liittyen
Legal Proceedings Report Classification · 99% confidence The document is a short press release (1303 characters) from Optomed Oyj, titled 'Optomed Oyj - Muut pörssin sääntöjen nojalla julkistettavat tiedot' (Other information to be disclosed under stock exchange rules). It explicitly states that there is no update regarding the FDA approval process for their product and that the company will inform when there is news. This structure—a brief announcement stating the status of a specific regulatory/business item and promising future updates—fits the definition of a general regulatory announcement that doesn't fit a more specific category like ER, IR, or CAP. Given its brevity and nature as a general disclosure under stock exchange rules, the most appropriate fallback category is Regulatory Filings (RNS). It is not a Report Publication Announcement (RPA) because it is not announcing the publication of a major report, but rather providing a status update on an ongoing regulatory matter.
2024-04-29 Finnish
No updates on the Optomed Aurora AEYE FDA clearance process
Legal Proceedings Report Classification · 99% confidence The document is very short (1180 characters) and is titled 'Optomed Plc Stock Exchange Release'. It provides a brief update stating there is 'No new information regarding the FDA clearance process' and promises to update the market when new information becomes available. This structure—a short announcement regarding an ongoing regulatory/business process without providing detailed financial results or comprehensive reports—fits best under the general regulatory announcement category, as it doesn't specifically match ER, IR, LTR, or any other specific filing type. Given the nature of a brief, non-scheduled update on a specific business item, the most appropriate fallback is Regulatory Filings (RNS). It is not an announcement of a report publication (RPA) because it is not announcing the release of a major document like a 10-K or IR.
2024-04-29 English
5b - Optio-ohjelmat 2017B, 2018C, 2019A ja 2019C (ehdotetuin muutoksin).pdf
Share Issue/Capital Change Classification · 85% confidence The document contains the detailed terms and conditions for Optomed Oyj's stock option programs (2017B and 2018C). It outlines the rules for granting options, exercise prices, vesting periods, and procedures in special corporate events like mergers or takeovers. This is a formal governance and incentive plan document rather than a financial report, earnings release, or simple announcement. Given that it details the structure of equity-based compensation and capital changes, it falls under the category of regulatory filings related to corporate governance and share capital structure.
2024-04-12 Finnish
Kutsu Optomed Oyj:n varsinaiseen yhtiökokoukseen
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Kutsu Optomed Oyj:n varsinaiseen yhtiökokoukseen' (Notice of the Annual General Meeting of Optomed Oyj). It outlines the agenda, voting procedures, and proposals for the upcoming AGM. According to the provided definitions, documents that provide information and request votes for meetings are classified as Proxy Solicitation & Information Statement (PSI).
2024-04-12 Finnish
Kutsu Optomed Oyj:n varsinaiseen yhtiökokoukseen
Share Issue/Capital Change Classification · 95% confidence The document text details the terms and conditions for two separate employee stock option programs ('OPTIO-OHJELMA 2017B' and 'OPTIO-OHJELMA 2018C') issued by Optomed Oyj. It covers the granting, allocation, exercise price, transfer restrictions, and conditions for share subscription related to these options. This content relates directly to the company's capital structure and employee incentive plans involving shares. While it is a detailed document, it is not a standard regulatory filing like a 10-K or an Earnings Release (ER). It specifically outlines the mechanics of a capital/financing instrument (stock options) provided to employees as part of a compensation/incentive scheme. This aligns best with the 'Capital/Financing Update' (CAP) category, as it defines the terms under which new capital (shares) can be raised via option exercise, or it could be considered a specific type of governance/incentive document. Given the focus on the terms of issuing rights to acquire capital, CAP is the most appropriate fit over general regulatory filings (RNS) or management disclosures (MANG/MDA).
2024-04-12 Finnish
Notice of the Annual General Meeting of Optomed Plc
Share Issue/Capital Change Classification · 95% confidence The document text details the 'TERMS AND CONDITIONS OF OPTION RIGHTS' and 'TERMS AND CONDITIONS OF SUBSCRIPTION FOR THE SHARES' related to an equity-based incentive program (Stock Option Plan 2018C). It outlines the issuance, allocation, subscription price, and transfer prohibitions for option rights intended for employees and consultants. This type of document, which establishes the rules for issuing capital instruments (options leading to shares) as part of an incentive scheme, is fundamentally related to capital structure changes and financing activities, although it is not a direct financing announcement like a debt issuance. However, among the provided codes, 'Capital/Financing Update (CAP)' is the most appropriate fit as it deals directly with the terms under which new shares can be issued via options, affecting the capital structure. It is not an earnings release (ER), an annual report (10-K), or a general regulatory filing (RNS). It is a specific set of terms governing future capital changes.
2024-04-12 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.